nivolumab
bms
['nivolumab', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nivo']
michiel van der heijden highlighting we may need to wait a long time for os data with adjuvant nivolumab because the statical plan. as he points out, it s a second endpoint and the trial is already +ve. he also shows the sap has some wiggle room #gu23 i hope we see a signal soon 
Interested in Urology Cancers, biomarkers and drug development.